Warning: The NCBI web site requires JavaScript to function. more...
A retrospective evaluation of patients switched from buprenorphine (Subutex) to the buprenorphine/naloxone combination (Suboxone).
Simojoki K, Vorma H, Alho H.
Subst Abuse Treat Prev Policy. 2008 Jun 17;3:16.
Related citations
Early experience with Suboxone maintenance therapy in Hungary.
Demetrovics Z, Farkas J, Csorba J, Németh A, Mervó B, Szemelyácz J, Fleischmann E, Kassai-Farkas A, Petke Z, Oroján T, Rózsa S, Rigó P, Funk S, Kapitány M, Kollár A, Rácz J.
Neuropsychopharmacol Hung. 2009 Dec;11(4):249-57.
Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centre.
Stimolo C, Favero VD, Zecchinato G, Buson R, Cusin D, Pellachin P, Simonetto P.
Clin Drug Investig. 2010;30 Suppl 1:27-31. doi: 10.2165/11536030-000000000-00000.
Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.
Magnelli F, Biondi L, Calabria R, Fiore A, Peluso E, Vonella D, Rota AG.
Clin Drug Investig. 2010;30 Suppl 1:21-6. doi: 10.2165/11536010-000000000-00000.
Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users.
Alho H, Sinclair D, Vuori E, Holopainen A.
Drug Alcohol Depend. 2007 Apr 17;88(1):75-8. Epub 2006 Oct 19.
Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
[No authors listed]
Prescrire Int. 2007 Dec;16(92):232-5.
Therapeutic switch to buprenorphine/naloxone from buprenorphine alone: clinical experience in an Italian addiction centre.
Montesano F, Zaccone D, Battaglia E, Genco F, Mellace V.
Clin Drug Investig. 2010;30 Suppl 1:13-9. doi: 10.2165/11536040-000000000-00000.
Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.
Amass L, Ling W, Freese TE, Reiber C, Annon JJ, Cohen AJ, McCarty D, Reid MS, Brown LS, Clark C, Ziedonis DM, Krejci J, Stine S, Winhusen T, Brigham G, Babcock D, Muir JA, Buchan BJ, Horton T.
Am J Addict. 2004;13 Suppl 1:S42-66.
Buprenorphine maintenance: a new treatment for opioid dependence.
Collins GB, McAllister MS.
Cleve Clin J Med. 2007 Jul;74(7):514-20. Review.
Buprenorphine in the treatment of opiate dependence.
Wesson DR, Smith DE.
J Psychoactive Drugs. 2010 Jun;42(2):161-75.
Clinical experience with fortnightly buprenorphine/naloxone versus buprenorphine in Italy: preliminary observational data in an office-based setting.
Amato P.
Clin Drug Investig. 2010;30 Suppl 1:33-9. doi: 10.2165/11536060-000000000-00000.
Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts.
Fudala PJ, Yu E, Macfadden W, Boardman C, Chiang CN.
Drug Alcohol Depend. 1998 Mar 1;50(1):1-8.
A pilot study of buprenorphine-naloxone combination tablet (Suboxone) in treatment of opioid dependence.
Bell J, Byron G, Gibson A, Morris A.
Drug Alcohol Rev. 2004 Sep;23(3):311-7.
The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence.
Mammen K, Bell J.
Expert Opin Pharmacother. 2009 Oct;10(15):2537-44. Review.
The diverse clinical uses of opioid receptor drugs.
Howland RH.
J Psychosoc Nurs Ment Health Serv. 2010 May;48(5):11-4.
A pilot study about the feasibility and cost-effectiveness of electronic compliance monitoring in substitution treatment with buprenorphine-naloxone combination.
Tacke U, Uosukainen H, Kananen M, Kontra K, Pentikänen H.
J Opioid Manag. 2009 Nov-Dec;5(6):321-9.
Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence.
Orman JS, Keating GM.
Drugs. 2009;69(5):577-607. doi: 10.2165/00003495-200969050-00006. Review.
Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers.
Mendelson J, Jones RT, Welm S, Baggott M, Fernandez I, Melby AK, Nath RP.
Psychopharmacology (Berl). 1999 Jan;141(1):37-46.
Pharmacokinetics, bioavailability and opioid effects of liquid versus tablet buprenorphine.
Compton P, Ling W, Moody D, Chiang N.
Drug Alcohol Depend. 2006 Mar 15;82(1):25-31. Epub 2005 Sep 6.
Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers.
Strain EC, Stoller K, Walsh SL, Bigelow GE.
Psychopharmacology (Berl). 2000 Mar;148(4):374-83.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on